Genmab's total assets for Q2 2025 were kr40.96B, a decrease of 0.00% from the previous quarter. GMAB total liabilities were kr7.36B for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.